Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Castellano

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
Cancer Metastasis Reviews|February 12, 2011
Current knowledge on diagnosis and staging of neuroendocrine tumorsKjell Oberg, Daniel Castellano
Cancer Metastasis Reviews|February 18, 2011
Future perspectives on neuroendocrine tumorsDaniel Castellano, Ramón Salazar, Eric Raymond
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 19, 2015
Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): Case report and review of the literatureGuillermo de Velasco, Cesar Munoz, Juan M Sepulveda, et al.
Cancer Metastasis Reviews|November 23, 2011
Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?Enrique Grande, Jaume Capdevila, Jorge Barriuso, et al.
Medicine|November 26, 2019
Three case reports: Temporal association between tyrosine-kinase inhibitor-induced hepatitis and immune checkpoint inhibitors in renal cell carcinomaAlberto Carretero-González, Javier Salamanca Santamaría, Daniel Castellano, et al.
Cancer Treatment Reviews|June 1, 2012
Therapy management with sunitinib in patients with metastatic renal cell carcinoma: key concepts and the impact of clinical biomarkersDaniel Castellano, Alain Ravaud, Manuela Schmidinger, et al.
Cancer|August 12, 2004
Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neckRicardo Hitt, Antonio Jimeno, Jose María Millán, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|June 17, 2020
Epigenetic regulation of white adipose tissue in the onset of obesity and metabolic diseasesDaniel Castellano-Castillo, Bruno Ramos-Molina, Fernando Cardona, et al.
Cancer Metastasis Reviews|April 17, 2013
The targeted therapy revolution in neuroendocrine tumors: in search of biomarkers for patient selection and response evaluationSara De Dosso, Enrique Grande, Jorge Barriuso, et al.
Medical Oncology (Northwood, London, England)|February 21, 2019
Best treatment options for advanced renal cell carcinoma (RCC) patients: a Delphi consensus studyJosé Luis Pérez-Gracia, Daniel Castellano, Miguel Ángel Climent, et al.
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Cancer Metastasis Reviews|February 12, 2011
Current knowledge on diagnosis and staging of neuroendocrine tumorsKjell Oberg, Daniel Castellano
Cancer Metastasis Reviews|February 18, 2011
Future perspectives on neuroendocrine tumorsDaniel Castellano, Ramón Salazar, Eric Raymond
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 19, 2015
Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): Case report and review of the literatureGuillermo de Velasco, Cesar Munoz, Juan M Sepulveda, et al.
Cancer Metastasis Reviews|November 23, 2011
Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?Enrique Grande, Jaume Capdevila, Jorge Barriuso, et al.
Medicine|November 26, 2019
Three case reports: Temporal association between tyrosine-kinase inhibitor-induced hepatitis and immune checkpoint inhibitors in renal cell carcinomaAlberto Carretero-González, Javier Salamanca Santamaría, Daniel Castellano, et al.
Cancer Treatment Reviews|June 1, 2012
Therapy management with sunitinib in patients with metastatic renal cell carcinoma: key concepts and the impact of clinical biomarkersDaniel Castellano, Alain Ravaud, Manuela Schmidinger, et al.
Cancer|August 12, 2004
Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neckRicardo Hitt, Antonio Jimeno, Jose María Millán, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|June 17, 2020
Epigenetic regulation of white adipose tissue in the onset of obesity and metabolic diseasesDaniel Castellano-Castillo, Bruno Ramos-Molina, Fernando Cardona, et al.
Cancer Metastasis Reviews|April 17, 2013
The targeted therapy revolution in neuroendocrine tumors: in search of biomarkers for patient selection and response evaluationSara De Dosso, Enrique Grande, Jorge Barriuso, et al.
Medical Oncology (Northwood, London, England)|February 21, 2019
Best treatment options for advanced renal cell carcinoma (RCC) patients: a Delphi consensus studyJosé Luis Pérez-Gracia, Daniel Castellano, Miguel Ángel Climent, et al.
Pageof 27